# Safety Reporting Requirements for INDs and BA/BE Studies:  Guidance for Industry and Investigators – FDA Guidance

Source: https://www.keypedia.com/guidances/small-entity-compliance-guide/safety-reporting-requirements-for-inds-and-babe-studies-guidance-for-industry-and-investigators/5e899308-bd5d-4267-9d7e-71f434a2b8db

> FDA guidance document: Safety Reporting Requirements for INDs and BA/BE Studies:  Guidance for Industry and Investigators. Issue date: December 20, 2012. Get complete insights and analysis.

---

## Details

- Title: Safety Reporting Requirements for INDs and BA/BE Studies:  Guidance for Industry and Investigators
- Communication Type: Small Entity Compliance Guide
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-12-20
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0482">FDA-2010-D-0482</a>

## Related Documents

- [S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals](https://www.keypedia.com/guidances/guidance-document/s6-r1-addendum-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/de0d3a32-bb96-4225-a321-61404f42a946)
- [Q11 Development and Manufacture of Drug Substances](https://www.keypedia.com/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)
- [Safety Reporting Requirements for INDs (Investigational New Drug Applications) and BA/BE (Bioavailability/Bioequivalence) Studies:  Guidance for Industry and Investigators](https://www.keypedia.com/guidances/guidance-document/safety-reporting-requirements-for-inds-investigational-new-drug-applications-and-babe-bioavailabilitybioequivalence-studies-guidance-for-industry-and-investigators/9528f5d8-c247-4fdc-8dc2-a32ec6d6afad)